Leveraging biological buffers for efficient messenger RNA delivery via lipid nanoparticles MI Henderson, Y Eygeris, A Jozic, M Herrera, G Sahay Molecular pharmaceutics 19 (11), 4275-4285, 2022 | 20 | 2022 |
Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis–based cell and mice models A Mukherjee, KD MacDonald, J Kim, MI Henderson, Y Eygeris, G Sahay Science advances 6 (47), eabc5911, 2020 | 20 | 2020 |
Quantifying lipid nanoparticle-mediated GFP expression in the murine retina. A Curtis, M Henderson, Y Eygeris, W Tschetter, G Sahay, RC Ryals Investigative Ophthalmology & Visual Science 64 (8), 5027-5027, 2023 | 1 | 2023 |
Quantifying lipid nanoparticle-mediated gene editing and morphological changes in murine retinal pigmented epithelium GLN Su, Y Eygeris, AG Curtis, A Jozic, M Gautam, M Henderson, G Sahay, ... Investigative Ophthalmology & Visual Science 65 (7), 6072-6072, 2024 | | 2024 |
Preformed Vesicle Approach to LNP Manufacturing Enhances Retinal mRNA Delivery Y Eygeris, MI Henderson, AG Curtis, A Jozić, J Stoddard, R Reynaga, ... Small, 2400815, 2024 | | 2024 |
Immune sensitization of melanoma to checkpoint inhibitor therapy using acoustically active nanoparticles MI Henderson, L Xiang, S Drennan, X Yi, J Fischer, A Yildirim Cancer Research 84 (6_Supplement), 5081-5081, 2024 | | 2024 |
Studies Towards the Synthesis of Novel Oxadiazole Derivatives for Antibiotic Screening Against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. P Hewes, M Henderson | | 2021 |
Engineered mutant a-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis-based cell and mice models M Henderson | | 2021 |
Liposomes vs Lipid Nanoparticle (LNP) Antibiotic Entrapment Efficiency Utilizing Fluorescein Dye M Henderson | | 2021 |